We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Yourgene Health Plc | LSE:YGEN | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.515 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/1/2022 11:37 | Can you now see any similarities, Twix? | handygandhi | |
05/1/2022 11:13 | Give upGive upGive upI stated markets currently stable and up.We're not talking about what will happen as that's a crash. you talked about what's happening now. All I see is nothing related to your comment. Spill the beans if you can? | twix386 | |
05/1/2022 10:50 | You have three guesses, Twix. | handygandhi | |
05/1/2022 10:43 | In what way? Markets fairly stable and up | twix386 | |
05/1/2022 10:30 | I think the Theranos fiasco is affecting market sentiment. | handygandhi | |
29/12/2021 14:49 | yes, hopefully proving their worth to the govt for the future. Plenty of non covid work to do too. As mentioned previously the NHS is way way behind with oncology testing for starters! | hjb1 | |
29/12/2021 14:25 | Don't be surprised if they continue winning more govt work well beyond COVID.They are doing very well with gaining confidence in the govt depts. More to come there no doubt | birdie12 | |
29/12/2021 14:19 | a lot depends how much they can make up for the eventual covid testing shortfall.They apparently already have a good expanding pipeline of potential post covid, so one eye on that, which is good to see. Much news to come in the next few weeks/months,looking forward to it! | hjb1 | |
29/12/2021 14:08 | I look at it as capex is largely done for now so no need for funds there. Of course if they can see something worth acquiring then of course it might be a mix of mainly debt and some smallish dilution. If it's going to enhance the overall income and business, then not a problem for me. I think they will consolidate for now and grow from what they have. | hjb1 | |
28/12/2021 22:25 | better still tells everyone he's in profit..ffs! You couldn't make it up, ah bless! | hjb1 | |
28/12/2021 22:23 | another year of total dross to come from moronic Twix.. Copy and paste from today and read the same in 12 months time..lol. Trader supreme selling his £1.50 shares for 16p ha ha ha ha!! | hjb1 | |
28/12/2021 22:07 | Consistently wrong idiot spouts off as usual. Pmsl | twix386 | |
28/12/2021 21:21 | Absolutely. Bolt us on for 20p+ ASAPFew these days would complain I suspect and I really think we would get over 20p. What's the delay!!..........Oh yes delays. Seen a few lol | twix386 | |
28/12/2021 21:19 | LR also reckons there might well be longer term contracts from govt depts. I tend to agree as they seem to be picking them up regularly now and proving their worth time and again. They can certainly help with all the oncology testing that's miles behind now. | hjb1 | |
28/12/2021 21:13 | Yes we were slow to covid as delayed by early partnership route with reluctance to engage directly ourselves. Not just the revenue missed but think where we would have progresed to by now having been earlier and contract sales/wins. Would have been a completely different path and story to current situation than 12p pants! Also same situation delaying engaging on govt.At least we did engage as not doing so would have us in single figures now!! | twix386 | |
28/12/2021 21:03 | ''The high risk is evidenced by 2 years of revenue buys the whole company''. Really, how did you work that out then? Are you just c/p all your ''knowledge'' ? | hjb1 | |
28/12/2021 20:43 | not to mention the big US customers and the excellent Ranger tech. Maybe Labcorp will adopt the tech bigtime, we will see! | hjb1 | |
28/12/2021 20:32 | 😇 Revenue per worker about £125k is low. About 280 workers and some 7 or so jobs on offer last time I looked. LR had to say there won't be any dilution - never believe anything until it is officially denied. This is an £87m market cap company rolling out advanced technology worldwide and management has saved the company by reacting swiftly to a covid opportunity to keep the company going. The high risk is evidenced by 2 years of revenue buys the whole company. apad | apad | |
28/12/2021 20:04 | the extra costs is mainly setting up labs for Ukas accreditation and staff to cope with all the extra testing. This cost/outlay will all start coming back now! As and when the testing drops off, so will the extra bods employed. There are many on short term contracts that will go when needed. Might not be for a while yet though. | hjb1 | |
28/12/2021 19:57 | From recent half-year results. "As cash generation and balance sheet strength improve, and in response to shareholder feedback at the time of the AGM, the Company is reviewing its capital structure with a view to accessing manageable debt facilities where appropriate to fund future growth." | cottoner |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions